Unsticking the Broken Diabetic Heart: O-GlcNAcylation and Calcium Sensitivity
نویسنده
چکیده
Cardiovascular disease is the leading cause of death in patients with diabetes. However, identifying mechanisms of disease progression has proven difficult as diabetes involves dysfunction of numerous pathways including cellular signaling and mitochondrial capacity. This results in the alteration of circulating hormones and nutrients that can lead to inflammation, oxidative stress, endoplasmic reticulum stress, lipotoxicity, and glucotoxicity (1). One hallmark of diabetes is the development of hyperglycemia and one goal of patient care is to control glycemia through the modification of lifestyle and drug therapy. However, the effectiveness of antihyperglycemia drugs on the development of heart failure in individuals with diabetes is not fully understood (2). Part of this challenge results from an incomplete understanding of how glucose regulates molecular function. Over 30 years ago, Torres and Hart (3) identified a unique posttranslational modification (PTM) by glycosylation of intracellular proteins via addition of an O-linked b-N-acetyl-D-glucosamine (O-GlcNAc), termed O-GlcNAcylation. Owing to the input of multiple metabolic pathways to generate uridine diphosphate (UDP)GlcNAc, the substrate of O-GlcNAcylation, this PTM gained attention as the link between metabolism and chronic disease (4). Increases in glucose associated with diabetes lead to excess O-GlcNAcylation and represent a crucial link between glucose and molecular regulation. Similar to protein phosphorylation, O-GlcNAcylation occurs at serine and threonine residues in proteins. It has been identified on;4,000 targets across most cellular pathways, as reviewed by Bond and Hanover (5). Unlike other PTMs that may have dozens if not hundreds of proteins modulating levels, two enzymes control O-GlcNAc cycling: O-GlcNAc transferase (OGT) for its addition and OGlcNAcase (OGA) for its removal. One point of regulation comes from the few splice variants of the genes encoding these proteins that show differing subcellular localization, including the nucleus to alter gene expression (6) and the mitochondria to regulate metabolism (7). The apparent promiscuous nature of this modification has made defining specificity of regulation difficult. In this issue of Diabetes, Ramirez-Correa et al. (8) identify a new mechanism of subcellular redistribution of the O-GlcNAcylation machinery, providing a means by which this pathway may be regulated in the diabetic heart. Examining myofilaments from the hearts of streptozotocin-induced diabetic rats, the authors found increased O-GlcNAcylation associated with decreased Ca sensitivity. Using b-elimination/Michael addition with Tandem Mass Tags (TMT), they specifically map the O-GlcNAcylation to 63 sites on six different myofilament proteins. Removal of excessO-GlcNAc levels with the bacterial glycosidase Clostridium perfringens N-acetyl-glycosidase J (CpOGA) restores myofilament Ca sensitivity in skinned cardiac muscles isolated from diabetic rats. However, the most novel discovery of the current study is the finding that basal levels of O-GlcNAc in both rodent and human myocardium localize to the Z-line and that this localization spreads toward the A-band and intensifies in streptozotocin-induced diabetes. This suggests that the increased O-GlcNAcylation found in pan-O-GlcNAc blots might be missing part of the picture. To begin to define the mechanism of this redistributed pattern, the authors used a series of immunoprecipitations and double immunoelectron microscopy to show that OGT and OGA sarcomeric distribution is inverted, altering O-GlcNAc levels and calcium sensitivity in the diabetic myocardium (Fig. 1). This suggests that the location of the O-GlcNAcylation machinery within the cell partially dictates its function and might explain some of the physiological and pathological roles of this PTM. O-GlcNAcylation modifies a number of pathways to regulate cellular function. It therefore becomes difficult to define cause and effect. The changes in calcium signaling may also result from O-GlcNAc regulation of Ca cycling either through modification of regulating transcription factors decreasing expression of sarcoendoplasmic reticulum Ca ATPase 2a (SERCA2a) (9) or
منابع مشابه
Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart.
To examine whether excessive protein O-GlcNAcylation plays a role in the dysfunction of the diabetic heart, we delivered adenovirus expressing O-GlcNAcase (Adv-GCA) into the myocardium of STZ-induced diabetic mice. Our results indicated that excessive cellular O-GlcNAcylation exists in the diabetic heart, and that in vivo GCA overexpression reduces overall cellular O-GlcNAcylation. Myocytes iso...
متن کاملRemoval of Abnormal Myofilament O-GlcNAcylation Restores Ca2+ Sensitivity in Diabetic Cardiac Muscle
Contractile dysfunction and increased deposition of O-linked β-N-acetyl-d-glucosamine (O-GlcNAc) in cardiac proteins are a hallmark of the diabetic heart. However, whether and how this posttranslational alteration contributes to lower cardiac function remains unclear. Using a refined β-elimination/Michael addition with tandem mass tags (TMT)-labeling proteomic technique, we show that CpOGA, a b...
متن کاملExcess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy.
We examined the role that enzymatic protein O-GlcNAcylation plays in the development of diabetic cardiomyopathy in a mouse model of Type 2 diabetes mellitus (DM2). Mice injected with low-dose streptozotocin and fed a high-fat diet developed mild hyperglycemia and obesity consistent with DM2. Studies were performed from 1 to 6 mo after initiating the DM2 protocol. After 1 mo, DM2 mice showed inc...
متن کاملDiabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria.
Elevated mitochondrial O-GlcNAcylation caused by hyperglycemia, as occurs in diabetes, significantly contributes to mitochondrial dysfunction and to diabetic cardiomyopathy. However, little is known about the enzymology of mitochondrial O-GlcNAcylation. Herein, we investigated the enzymes responsible for cycling O-GlcNAc on mitochondrial proteins and studied the mitochondrial transport of UDP-G...
متن کاملHexosamine biosynthetic pathway flux and cardiomyopathy in type 2 diabetes mellitus. Focus on "Impact of type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart".
THE DEVELOPED WORLD IS CURRENTLY experiencing an epidemic of type 2 diabetes mellitus, with an estimated worldwide prevalence of 140 million cases (16). Among the end organs affected by diabetes is the myocardium, which has been demonstrated to exhibit a constellation of structural and functional abnormalities known collectively as diabetic cardiomyopathy. While historically it has been somewha...
متن کامل